Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-707
Closed -$40.5K – 6729
2025
Q4
$40.5K Buy
+707
New +$29.8K ﹤0.01% 6302
2021
Q3
– Sell
-1,814
Closed -$140K – 6347
2021
Q2
$140K Buy
+1,814
New +$144K ﹤0.01% 5864
2020
Q3
– Sell
-949
Closed -$21K – 5424
2020
Q2
$21K Hold
949
– – ﹤0.01% 5124
2020
Q1
$14K Buy
+949
New +$39.9K ﹤0.01% 5151

Other funds holding IMMP

Goldman Sachs's IMMP Position: Q1 2026 in Review

Goldman Sachs sold out of Immutep (IMMP) in Q1 2026, closing a stake of 707 shares — an estimated $40.5K sold.

Goldman Sachs first reported a position in IMMP in Q1 2020 and held it in 4 quarters. The position peaked at $140K in Q2 2021. 24 funds tracked by Wall St. Rank hold IMMP as of Q1 2026.

  • Goldman Sachs reported no remaining Immutep position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 707 Immutep shares in Q1 2026, an estimated $40.5K.
  • Goldman Sachs first reported a position in Immutep in Q1 2020 and held it in 4 quarters.
  • Goldman Sachs's Immutep position peaked at $140K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Immutep as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.